Ergoteles LLC Syndax Pharmaceuticals Inc Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $1.33 Million - $1.53 Million	68,764 New	68,764 $1.44 Million
Q1 2022 May 13, 2022	SELL	$14.84 - $22.15 $519,355 - $775,183	-34,997 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $183,841 - $271,235	-12,071 Reduced 25.65%	34,997 $766,000
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $652,833 - $931,946	47,068 New	47,068 $899,000

228

89.9M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $802M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.